History of Cannabis Smoking and Subjective Cognitive Complaints in Older Women
Neuroepidemiology · 08.01.2026 · 1-11
DOI: 10.1159/000550276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroepidemiology, online erschienen am 08.01.2026. Verfasst von Guoyong Ding und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, Michigan, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Introduction
Cannabis use has been increasing in the USA, yet its potential long-term effects on neurocognitive outcomes remain unknown. We aimed to examine the association of the history of cannabis smoking with subjective cognitive complaints (SCC) in older women.
Methods
This prospective cohort analysis included 15,378 older women (age ≥65 years) of the USA from the National Institute of Environmental Health Sciences’ Sister Study. Participants reported their history of cannabis smoking at enrollment (2003–2009) and completed the Eight-item Interview to Differentiate Aging and Dementia (AD8) as an SCC screener at the cohort’s 2nd (2011–2014), 3rd (2014–2016), and 4th (2017–2019) follow-ups. We used multivariable joint models to assess the association.
Results
Overall, 3,973 (25.8%) women reported ever smoking cannabis, mostly in their early adulthood. Compared with never cannabis smokers, the multivariable odds ratios (ORs) for ever smokers were 1.27 (95% confidence interval [CI]: 1.13, 1.43) at the 2nd follow-up, 1.28 (95% CI: 1.14, 1.44) at the 3rd follow-up, and 1.30 (95% CI: 1.11, 1.52) at the 4th follow-up. Associations were stronger for regular than occasional cannabis smokers. For example, at the 2nd follow-up, the OR was 1.61 (95% CI: 1.31, 1.98) for regular smokers and 1.19 (95% CI: 1.04, 1.35) for occasional smokers. Results were overall consistent in subgroup and sensitivity analyses.
Conclusions
This study suggests a potential association between a history of cannabis smoking and SCC in older women, calling for further research on cannabis use and cognitive outcomes in the context of aging.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, Michigan, USA.
- Department of Epidemiology, School of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
- Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA.
- Social and Scientific Systems, DLH Holdings Corporation, Durham, North Carolina, USA.
- Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, US Department of Health and Human Services, Research Triangle Park, North Carolina, USA.
- Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, Michigan, USA, chenho19@msu.edu.
Förderung
- Intramural NIH HHS
Zitieren
APA
Ding, G., Bohnert, K. M., Li, C., Plassman, B. L., Liang, X., Yuan, Y., D'Aloisio, A. A., White, A. J., Sandler, D. P., & Chen, H. (2026). History of Cannabis Smoking and Subjective Cognitive Complaints in Older Women. Neuroepidemiology, 1-11. https://doi.org/10.1159/000550276
Vancouver
Ding G, Bohnert KM, Li C, Plassman BL, Liang X, Yuan Y, et al. History of Cannabis Smoking and Subjective Cognitive Complaints in Older Women. Neuroepidemiology. 2026:1-11. doi:10.1159/000550276
BibTeX
@article{Ding2026,
author = {Ding, Guoyong and Bohnert, Kipling M and Li, Chenxi and Plassman, Brenda L and Liang, Xiaoyu and Yuan, Yaqun and D'Aloisio, Aimee A and White, Alexandra J and Sandler, Dale P and Chen, Honglei},
title = {History of Cannabis Smoking and Subjective Cognitive Complaints in Older Women},
journal = {Neuroepidemiology},
year = {2026},
pages = {1--11},
doi = {10.1159/000550276}
}
EUVIMED